title: A brain cancer pathway in clinical practice.
abstract: BACKGROUND
  Danish healthcare seeks to improve cancer survival through improved diagnostics, rapid treatment and increased focus on cancer prevention and early help-seeking. In neuro-oncology, this has resulted in the Integrated Brain Cancer Pathway (IBCP). The paper explores how the pathway works in the initial phase in a clinical setting with emphasis on pathway criteria.
  
  
  METHODS
  All patients admitted during the first two-year period to a regional neurology department in Denmark and fulfilling the IBCP inclusion criteria were included. Data regarding onset symptoms, diagnosis and time for diagnostic work-up were obtained and supplemented by a retrospective review of patient records. Sensitivities, specificities and positive predictive values of the inclusion criteria were calculated with magnetic resonance imaging scan of the cerebrum as index of validity.
  
  
  RESULTS
  The strength of the pathway inclusion criteria was determined largely by the number of criteria fulfilled and by the type of predominant symptoms. The criteria identified the majority of patients with symptomatic brain malignancy and were also highly predictive of general structural brain lesions.
  
  
  CONCLUSIONS
  The introduction of the pathway is a major step forward in the efforts to optimize brain cancer patients' illness trajectory.
  
  
  BACKGROUND
  This study was funded by a grant from the Danish Ministry of Health and Interior Affairs 2009 and the Helen Rude Foundation and has been approved by the Danish Data Protection Agency.
  
  
  BACKGROUND
  not relevant.
authors.affiliation: Department of Neurology, Hillerød Hospital, Hillerød, Denmark. emilielundlaursen@hotmail.com
authors.forename: Emilie Lund
authors.initials: EL
authors.lastname: Laursen
authors.forename: Birthe Krogh
authors.initials: BK
authors.lastname: Rasmussen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000628:therapy; D019091:Critical Pathways; D003718:Denmark; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012017:Referral and Consultation; D012189:Retrospective Studies; D012680:Sensitivity and Specificity